123 employees
Neogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.
2018
$110M
from 7 investors over 7 rounds
Neogene Therapeutics raised $110M on September 14, 2020
Investors: JEITO, Syncona Limited, Pontifax Venture Capital, TPG Global, Polaris Partners, Vida Ventures, LLC and Two River